Johnson & Johnson Invests More Than $1 Billion to Strengthen U.S. Vision Manufacturing

The investment will expand U.S.-based manufacturing, packaging, and distribution capabilities. It also includes the construction of a new, state-of-the-art distribution facility and the addition of advanced manufacturing and packaging technologies to increase capacity and meet growing demand for the company’s ACUVUE® contact lenses.

The investment will expand U.S.-based manufacturing, packaging, and distribution capabilities by adding a new state-of-the-art distribution facility and advanced manufacturing and packaging technologies. This will increase capacity and help meet growing demand for the company’s ACUVUE® contact lenses.

Today’s announcement is part of the company’s previously announced $55 billion investment in U.S. manufacturing, R&D, and technology through early 2029. Construction of the new facility is already underway and is expected to be fully operational by 2028.

The investment builds on the company’s $6 billion annual economic impact in Florida and supports the continued growth of its Jacksonville operations. It is also expected to strengthen opportunities for the 3,500 employees in the region and further support the local economy.

For more than 40 years, Johnson & Johnson’s Jacksonville operations have supported eye health through innovative optical solutions that help improve how people see and experience the world. Today, the company manufactures more than 1.7 billion ACUVUE® contact lenses each year for patients in the United States.

Since opening in Jacksonville in 1981, Johnson & Johnson has played an important role in the region’s economic growth. It now contributes about $6 billion annually to Florida’s economy and operates over 1.5 million square feet of manufacturing, research, distribution, and operations facilities.

Read More:Landseed Receives $400K Social-Impact Investment

U.S. Senator Rick Scott: “Florida continues to play a leading role in strengthening America’s healthcare supply chain to serve patients better. The billion-dollar investment in Jacksonville will help expand the domestic capacity and strengthen America’s healthcare infrastructure. That means more jobs in Florida, a stronger national economy, less reliance on foreign healthcare products, and better results for our nation’s long-term health and competitiveness.”

U.S. Senator Ashley Moody: “I am thrilled to see this major $1 billion investment in our state, funding new state-of-the-art facilities and supporting jobs in the Jacksonville area. This is more than a simple investment – this represents a down payment on the future of Jacksonville and the state of Florida. Companies are moving to Florida in droves, and massive investment such as this highlights Florida as the nation’s top state to grow your family and your business.”

Representative John Rutherford, “Johnson & Johnsons continued investment in Jacksonville reflects the regions strength in advanced manufacturing, and critical healthcare production. It supports a skilled workforce strengthens domestic capacity and reinforces Northeast Floridas role in keeping America economically competitive.”

Representative Aaron Bean said Johnson & Johnson’s $1 billion investment in Jacksonville will strengthen the supply chain for important vision products, while also creating high-quality jobs and delivering significant economic benefits for Northeast Florida.

He added that the project reinforces Jacksonvilles position as a leading destination for healthcare manufacturing and innovation helping ensure the region remains at the forefront of supporting patients and advancing medical technology.

About Johnson & Johnson

Johnson & Johnson believes that health is essential to everything. The company focuses on healthcare innovation to help create a future where complex diseases can be prevented, treated, and cured, and where treatments are smarter, less invasive, and more personalized. Through its expertise in Innovative Medicine and MedTech, Johnson & Johnson works across the full range of healthcare solutions to deliver future breakthroughs and improve health outcomes for people around the world.

Read More:Persistent Announces Partnership with San Francisco Unicorns